Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News China SXT Pharmaceuticals Inc. SXTC

China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.


Recent & Breaking News (NDAQ:SXTC)

China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split

GlobeNewswire May 18, 2022

China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million

GlobeNewswire March 14, 2022

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).

Accesswire January 20, 2022

China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment

GlobeNewswire January 20, 2022

China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares

GlobeNewswire January 18, 2022

China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares

GlobeNewswire January 14, 2022

China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin

PR Newswire January 14, 2022

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

PR Newswire December 16, 2021

China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection

PR Newswire October 18, 2021

China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split

PR Newswire February 19, 2021

NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain Compliance with Bid Price Requirement

PR Newswire September 9, 2020

China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government

PR Newswire March 16, 2020

China SXT Pharmaceuticals, Inc. Announces Plans to Increase Production

Business Wire January 24, 2020

China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory

PR Newswire January 16, 2020

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

PR Newswire January 3, 2020

China SXT Pharmaceuticals, Inc. Granted to Establish Taizhou Research Center for Advanced TCMP Engineering Techniques

PR Newswire September 11, 2019

China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

PR Newswire August 19, 2019

China SXT Pharmaceuticals, Inc. Receives New Pharmaceutical GMP Certificate

PR Newswire August 12, 2019

China SXT Pharmaceuticals, Inc. Announces TCM Homologous Supplements Production

PR Newswire July 3, 2019

China SXT Pharmaceuticals, Inc. Being Admitted to Hi-tech Zone of Huangshan City in Anhui Province

PR Newswire May 22, 2019